PlusQuam Pharma is a pharmaceutical company specialized in the development of food supplements, medical devices, and cosmetic products, operating in the areas of urological health, women’s health, d...
The Asabys Innvierte Tech Transfer FCRE fund, specialised in biotechnology and medical technologies, will invest in the creation and development of innovative companies in the field of deep-tech appli...
Archipélago Next continues to accelerate the deployment of its second fund with the addition of three new companies to its portfolio: TietAI, Dolfin and Fresh People. Although operating in different ...
The group has announced the acquisition of the Italian company Medcomp, as well as the purchase of the production unit of Catalan medical supplier Sangüesa. With these two transactions, Saesco reache...
Visium has grown to a team of 100 AI experts across Europe and has delivered more than 250 AI and data solutions for global leaders in life sciences, specialty chemicals and other regulated industries...
The transaction represents an important milestone in sanotact’s continued development. Avista brings deep experience in consumer healthcare across North America and Europe, while Damier contributes ...
In 2025, 48% of M&A transactions in the healthcare sector in Spain involved the direct or indirect participation of financial investors, highlighting the growing interest of capital in this space
The dermatology and cosmetics sector continues to position itself as one of the most attractive areas within consumer markets, supported by strong structural demand linked to wellness, health, and per...
The total planned investment for the development is around €80 million, with the asset expected to be partially operational at the beginning of 2027. This financing represents one of the most signif...
Following its acquisition of the Avanta Group last year, H.I.G. Capital continues its expansion in the Iberian occupational health and safety (OHS) services market through the acquisition of a majorit...
The round was co-led by new investors Columbus Venture Partners and Mérieux Equity Partners, with participation from additional investors COFIDES and Korys, alongside all existing investors Alta Life...
Cuatrecasas advised Columbus Venture Partners and Mérieux Equity Partners on their participation as co-lead investors in Ona Therapeutics Series B financing. Ona Therapeutics is a pioneering biopharm...